Party Committee of Pharmaceutical Company Organize Concentrated Learning
Release time:
2020-07-22
Pharmaceutical Company organized a centralized study of
News from our newspaper 12# July 30# On the afternoon of the 9th, the Party Committee of Pharmaceutical Company held a meeting of Party Committee members, general party branches of various enterprises, party branch secretaries and committee members to attend a centralized party class.
" Two Books and One Chapter "to study further, " Do not forget your initiative mind, Remember Mission "to deepen the understanding" as the topic, from Xi Jinping's new era of socialism with Chinese characteristics, Xi Jinping's excerpt on "Do not forget your initiative mind, Keeping in mind mission " , the constitution of the Communist Party of China, "Do not forget your initiative mind, Keeping in mind mission " , the concept, historical background, connotation and core content of Xi Jinping's new era of socialism with Chinese characteristics are explained; xi Jinping's Discussion on Ten Aspects of Excerpts from "Do not forget your initiative mind, Keeping in Mind Mission " ; The historical status of the constitution of the Communist Party of China, the innovation of 11 in the amendment to the party constitution of the 19th CPC National Congress, and the general outline and sub-discussion of the party constitution; xi Jinping's important speech at the Politburo meeting and "Do not forget your initiative mind, Remember Mission " Theme Education General Requirements, Specific Objectives, and New Understanding of Theme Education.
"Do not forget your initiative mind, Remember Mission " theme education carried out by each unit in the previous stage. All party organizations have carried out various and colorful learning and education activities in accordance with the requirements of the Party Central Committee, the unified deployment of the group company, and the arrangement of the pharmaceutical company. Each unit conveyed the contents and requirements of the second batch of learning and education in an original way. They organized party classes. The Party branch of the sales company went to the cemetery of Liu Ying martyrs to present flower baskets to show their respect. The Party branch of the department went to the former residences of Feng Xuefeng, Wu Han and Ai Qing to learn the firm belief of the revolutionary predecessors. The Party committee of the company organized party members to visit the "Do not forget your initiative mind Mission " Special Exhibition Hall in Jinhua, each unit also contacted the actual situation of the enterprise to examine the problem, find the gap and grasp the implementation. The "Do not forget your initiative mind, Remember Mission " educational activity has achieved tangible results. Group Party Committee Member, Deputy General Manager, and General Manager of Pharmaceutical Company Huang Jinlong attended the meeting. He stressed the great significance of carrying out
Do not forget your initiative mind, Keeping in Mind Mission " theme education. He hoped that all Party members would strengthen political theory and business study, strictly abide by the bottom line, purify their thoughts, focus on enterprise development, dare to take responsibility, dare to act and be willing to contribute. Sincerely care for employees and solve their problems. The meeting also made arrangements for the work of the party organization in the new year. (This correspondent)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page